Pharmacovigilance for COVID-19 vaccines: A 1-year experience in France.

Crommelynck, S; Thill, P

Crommelynck, S; Thill, P.

Affiliation

Crommelynck S; ANSM, Department of Pharmacovigilance, Paris, France.
Thill P; Department of Infectious Diseases, Hospital Dron Tourcoing, France. Electronic address: pauline.thill@gmail.com.

Infect Dis Now ; 52(8S): S16-S18, 2022 Nov.

Article in En | MEDLINE | ID: mdl-36152793

Subject(s)

COVID-19 Vaccines; COVID-19; Pharmacovigilance; Humans; Adverse Drug Reaction Reporting Systems; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects

Key words

Adverse events; Covid 19; Myocarditis; Pharmacovigilance; Vaccine

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacovigilance / COVID-19 Vaccines / COVID-19 Limits: Humans Language: En Journal: Infect Dis Now Year: 2022 Document type: Article Affiliation country: France Country of publication: France

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google